Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PED-HZ/su in paediatric renal transplant recipients
NCT04006808Phase 2Recruiting
- Sponsor
- GSK
- Start
- Oct 2019
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 2 trial of PED-HZ/su in herpes zoster (HZ), sponsored by GSK. Started Oct 2019; status: recruiting.
02
Drugs
PED-HZ/su
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04006808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006808.